drugset / Trial / NCT06748651

Intra-articular Allocetra in Osteoarthritis of the of the Temporomandibular Joint (TMJ)

NCT06748651 ↗

Phase 1 Recruiting 6 enrolled Dr. Amit Druyan Sheba Medical Center · collab
NaSingle-groupOpen-labelTreatment

Summary

This study is a single center trial to assess the safety and initial efficacy of intra-articular administration of Allocetra to patients with Temporomandibular Joint Osteoarthritis (TMJ-OA)

Timeline

Start
2024-12-15
Primary completion
2026-02-07
Completion
2026-04-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Allocetra Cell therapy — Other